Sprycel
/
Sprycel (dasatinib) is a tyrosine kinase inhibitor indicated for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). It is available as an oral tablet and is a prescription medication. Patients are advised to monitor for potential side effects, including bleeding problems and fluid retention, and should not use Sprycel if they have a history of severe allergic reactions to dasatinib.
FAQs about Sprycel
What should I do if I miss a dose?
If you miss a dose of Sprycel, take it as soon as you remember on the same day. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Sprycel while pregnant or breastfeeding?
Sprycel may cause harm to an unborn baby, and it is not recommended for use during pregnancy. Women who are pregnant or may become pregnant should discuss the risks with their healthcare provider. It is also advised that women do not breastfeed while taking Sprycel, as it is not known if dasatinib passes into breast milk. This information is detailed in the Warnings and Precautions section of the label.
Can I stop taking Sprycel suddenly?
Patients are advised not to stop taking Sprycel without consulting their healthcare provider, as abrupt discontinuation may lead to disease progression. It is important to follow your prescriber\
25
commonly-prescribed
medication.